Ikarian Capital, LLC Biogen Inc. Put Options Transaction History

Ikarian Capital, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $10.4 Million - $14.3 Million	53,200 New	53,200 $14.2 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $52.3 Million - $78.7 Million	221,200 Added 159.37%	360,000 $88.1 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $36.8 Million - $42.4 Million	138,800 New	138,800 $39.4 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.